Croissance Clinical Research Private Limited, a active private limited company, was established on 16 May 2013 in Hyderabad, Telangana, India. Engaging in pharma contract r&d within the professional, scientific and technical sector, it holds CIN: U74900TG2013PTC087677. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹7.00 M and a paid-up capital of ₹6.82 M.
It upholds a compliant status. Employing 11 professional, Its leadership includes Bharathi Marukurthi (Director), Satish Yadav Marukurthi (Managing Director). Past directors included Venkateswarlu Kondraganti, Ramesh Bandaru, Satish Yadav Marukurthi. It holds ₹1.65 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No. 37, 2Nd Floor, Smarco Rahul, Matrusri Nagar Gate No. 5, Near Miyapur X Roads,, Miyapur, Hyderabad, Telangana, 500049.
U74900TG2013PTC087677
087677
16 May 2013
₹7.00 M
₹6.82 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Croissance Clinical Research Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Bharathi Marukurthi | Director | 01 Dec 2014 | Current |
| Satish Yadav Marukurthi | Managing Director | 16 May 2013 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 18 Jan 2014 | Past |
| Pramod Abcsdd | Director | 06 Aug 2013 | Past |
| Pramod Abcsdd | Director | 27 May 2013 | Past |
| Pramod Abcsdd | Additional Director | 10 Dec 2014 | Past |
| Pramod Abcsdd | Director | 05 Apr 2014 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Croissance Clinical Research Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 14.07% decrease. The company also saw a substantial fall in profitability, with a 34.07% decrease in profit. The company's net worth Soared by an impressive increase of 24.91%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Croissance Clinical Research had a public holding of 22.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹16,500,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Jan 2021 | Others | ₹6.50 M | Open |
| 10 Jul 2020 | Hdfc Bank Limited | ₹1.00 Cr | Open |
Explore comprehensive loan charge details -
Croissance Clinical Research has a workforce of 11 employees as of Apr 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Croissance Clinical Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Croissance Clinical Research's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Croissance Clinical Research Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Croissance Clinical Research Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was recorded as a recent event.
Progress on A charge with Hdfc Bank Limited of Rs. 10.00 M registered on 10 Jul 2020 with Charge ID 100352189 was modified on 04 Aug 2021. was documented.
A charge with Others amounted to Rs. 6.50 M with Charge ID 100443368 was registered on 28 Jan 2021. was recorded as a recent event.
The activity A charge with Hdfc Bank Limited amounted to Rs. 10.00 M with Charge ID 100352189 was registered on 10 Jul 2020. was completed.
Progress on Bharathi Marukurthi was appointed as a Director was appointed as a Director on 01 Dec 2014 & has been associated with this company since 10 years 11 months . was documented.
The CIN of Croissance Clinical Research Private Limited is U74900TG2013PTC087677.
Croissance Clinical Research Private Limited is headquartered at Plot No. 37, 2Nd Floor, Smarco Rahul, Matrusri Nagar Gate No. 5, Near Miyapur X Roads,, Miyapur, Hyderabad, Telangana, 500049.
Croissance Clinical Research Private Limited was incorporated on 16 May 2013.
The current directors of Croissance Clinical Research Private Limited are
The primary industry of Croissance Clinical Research Private Limited is Professional, Scientific And Technical.
Croissance Clinical Research Private Limited is unlisted.
The authorized capital of Croissance Clinical Research Private Limited is ₹7.00 M, and the paid-up capital is ₹6.82 M.
The compliance status of Croissance Clinical Research Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX